18F-FDG PET imaging in primary adrenal lymphoma
Creators
- 1. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
Description
Objective: To evaluate 18F-FDG PET/CT imaging in primary adrenal lymphoma (PAL). Methods: Three male patients with clinically diagnosed PAL, aged 59 to 77 years old, were examined by 18F-FDG PET/CT before histopathologic examination. The SUVmax ratio of tumor to liver (T/L) was calculated on 18F-FDG PET images. All patients underwent R-CHOP (rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy regimens. One patient had serial follow-up 18F-FDG PET/CT post therapy. Results: The final diagnosis of all 3 cases was bilateral diffuse large B-cell lymphoma. The pathologic results of bone marrow biopsy were negative. Case 1 was in disease remission based on four times of follow-up 18F-FDG PET/CT. The patient's clinical follow-up was also negative and he was currently alive for more than 19 months. Case 2 was of late stage and suffered from adrenal insufficiency. He died 6 months after the diagnosis. Case 3 (the eldest patient) was treated with partial excision followed by the chemotherapy. He died of lung infection 12 months after treatment. Conclusion: 18F-FDG PET/CT may be of important value for maximizing patient management and survival for patients with PAL, a rare and highly malignant disease. (authors)
Additional details
Publishing Information
- Journal Title
- Chinese Journal of Nuclear Medicine
- Journal Volume
- 31
- Journal Issue
- 4
- Journal Page Range
- p. 237-240
- ISSN
- 0253-9780
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 46111424
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ADRENAL GLANDS; BONE MARROW; CAT SCANNING; CHEMOTHERAPY; DIAGNOSIS; DOXORUBICIN; ELDERLY PEOPLE; ENDOXAN; FLUORINE 18; FLUORODEOXYGLUCOSE; LIVER; LUNGS; LYMPHOMAS; MALES; MEDICAL SURVEILLANCE; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; PREDNISONE; RADIOPHARMACEUTICALS; ULTRASONOGRAPHY
- Descriptors DEC
- ADRENAL HORMONES; ADULTS; AGE GROUPS; AGED ADULTS; ALKYLATING AGENTS; ANIMAL TISSUES; ANIMALS; ANTIBIOTICS; ANTI-INFECTIVE AGENTS; ANTIMETABOLITES; ANTINEOPLASTIC DRUGS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; CORTICOSTEROIDS; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; ENDOCRINE GLANDS; FLUORINE ISOTOPES; GLANDS; GLUCOCORTICOIDS; HEMATOPOIETIC SYSTEM; HORMONES; HOURS LIVING RADIOISOTOPES; HUMAN POPULATIONS; HYDROXY COMPOUNDS; IMMUNE SYSTEM DISEASES; IMMUNOSUPPRESSIVE DRUGS; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; KETONES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MAN; MATERIALS; MEDICINE; MINORITY GROUPS; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; POPULATIONS; PREGNANES; PRIMATES; RADIOACTIVE MATERIALS; RADIOISOTOPES; RESPIRATORY SYSTEM; STEROID HORMONES; STEROIDS; THERAPY; TOMOGRAPHY; VERTEBRATES
Optional Information
- Notes
- 2 figs., 2 tabs., 9 refs.